首页> 外文期刊>Substance Abuse Treatment, Prevention, and Policy >Roadside opioid testing of drivers using oral fluid: the case of a country with a zero tolerance law, Spain
【24h】

Roadside opioid testing of drivers using oral fluid: the case of a country with a zero tolerance law, Spain

机译:使用口服液对驾驶员进行路边阿片类药物测试:西班牙零容忍法国家的案例

获取原文
       

摘要

Background Opioids can impair psychomotor performance, and driving under the influence of opioids is associated with an increased risk of accidents. The goals of this study were i) to determine the prevalence of opioids (heroin, morphine, codeine, methadone and tramadol) in Spanish drivers and ii) to explore the presence of opioids, more specifically whether they are used alone or in combination with other drugs. Methods The 2008/9 DRUID database regarding Spain was used, which provided information on 3302 drivers. All drivers included in the study provided a saliva sample and mass-chromatographic analyses were carried out in all cases. To determine the prevalence, the sample was weighted according to traffic intensity. In the case of opioid use combinations, the sample was not weighted. The detection limit for each substance was considered a positive result. Results The prevalence of opioids in Spanish drivers was 1.8% (95% CI, 1.4–2.3). Polydrug detection was common (56.2%): of these, in two out of three cases, two opioids were detected and cocaine was also detected in 86% of the cases. The concentration (median [Q1-Q3] ng/ml) of the substances was low: methadone 1.71 [0.10–15.30], codeine 40.55 [2.10–120.77], 6-acetylmorphine 5.71 [1.53–84.05], and morphine 37.40 [2.84–200.00]. Morphine was always detected with 6-acetylmorphine (heroin use). Conclusions Driving under the influence of opioids is relatively infrequent, but polydrug use is common. Our study shows that 6 out of 10 drivers with methadone in their OF (likely in methadone maintenance programs) are using other substances. This should be taken into account by health professionals in order to properly inform patients about the added risks of mixing substances when driving.
机译:背景技术阿片类药物可能会损害精神运动能力,在阿片类药物的影响下驾驶会增加发生事故的风险。这项研究的目的是:i)确定西班牙驾驶员中阿片类药物(海洛因,吗啡,可待因,美沙酮和曲马多)的流行度;以及ii)探索阿片类药物的存在,更具体地说,是单独使用还是与其他药物联合使用毒品。方法使用有关西班牙的2008/9 DRUID数据库,该数据库提供了有关3302位驾驶员的信息。研究中包括的所有驱动程序均提供了唾液样本,并且在所有情况下均进行了质谱分析。为了确定流行程度,根据交通强度对样品进行加权。在使用阿片类药物组合的情况下,未对样品进行加权。每种物质的检出限被认为是阳性结果。结果西班牙驾驶员中阿片类药物的患病率为1.8%(95%CI,1.4-2.3)。多药检出很常见(56.2%):其中,三分之二的病例中检出了两个阿片类药物,86%的病例中也检出了可卡因。物质的浓度(中位数[Q1-Q3] ng / ml)低:美沙酮1.71 [0.10-15.30],可待因40.55 [2.10-120.77],6-乙酰吗啡5.71 [1.53-84.05]和吗啡37.40 [2.84] –200.00]。总是使用6-乙酰吗啡(使用海洛因)检测吗啡。结论在阿片类药物的影响下驾驶相对较少,但多药使用是常见的。我们的研究表明,在OF中有美沙酮的驾驶员中,十分之六(可能在美沙酮维持计划中)正在使用其他物质。卫生专业人员应考虑到这一点,以便在驾驶时适当告知患者混合物质增加的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号